Weight Management

Greater availability of the blockbuster drugs does not mean every older patient should get them.

Patient demand is high, but distinctions are fuzzy about compounded GLP-1s. Primary care physicians can help

When patients ask about compounded semaglutide or tirzepatide, practices need a repeatable way to document, triage and react

What primary care physicians should know about developing science that moves beyond skin substitutes.

An Obesity Action Coalition leader discusses latest developments in treatment of obesity as a chronic disease.

Here's a place to start the discussion when patients ask about one of the hottest issues across medicine and health care.

Mayo Clinic cardiologist authors explain why incremental steps can lead patients to better health and more joy in life.

What physicians should know about treatment options for patients with obesity — and why they need to be advocates

A new technology may help primary care physicians meet the growing need for comprehensive foot exams for patients with diabetes

A slideshow with steps to take for better physical and mental wellness this year.

More steps are needed, including insurance coverage that could help patients.

Proponents say the surgical procedures are underutilized and misunderstood in contemporary medicine.

With high demand but high prices for antiobesity drugs, patients may fall for phony pharmaceuticals.

Clinical and preclinical are distinctions that could guide patient treatment, public health and medical policy going forward, according to study commission.

It’s not too late to make a new year’s resolution to eat better. Here’s some good advice on eating for patients and physicians.

A slideshow with conversation starters for physicians and patients to evaluate factors affecting brain health at the start of a new year.

Robert Kushner, MD, an expert in overweight, obesity, nutrition, diet and exercise, discusses the effects of the new antiobesity medications.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Will it take effect? Biden proposal would be finalized in Trump’s term, and his pick to lead HHS has spoken against antiobesity drugs.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Obesity is a complex disease that requires treatment both individualized and multifaceted.

Senate HELP Committee grills Novo Nordisk CEO over prices of Ozempic, Wegovy. He says patients not getting needed medicines is ‘terrifying.’